Oberland Capital
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$2.4B
Focus Areas
5
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Ocular Therapeutix | $1.8B |
| Esperion Therapeutics | $654.9M |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Ocular Therapeutix | $1.8B |
| Esperion Therapeutics | $654.9M |